Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. OrganiGram Holdings Inc.
  6. Summary
    OGI   CA68620P1018

ORGANIGRAM HOLDINGS INC.

(OGI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
2.57(c) 2.61(c) 2.43(c) 2.5(c) 2.34(c) Last
1 886 622 2 728 829 1 933 283 1 573 979 2 011 249 Volume
-4.81% +1.56% -6.90% +2.88% -6.40% Change
More quotes
Estimated financial data (e)
Sales 2022 133 M 103 M 103 M
Net income 2022 -34,9 M -27,1 M -27,1 M
Net cash position 2022 165 M 129 M 129 M
P/E ratio 2022 -23,9x
Yield 2022 -
Sales 2023 183 M 142 M 142 M
Net income 2023 -21,0 M -16,4 M -16,4 M
Net cash position 2023 172 M 134 M 134 M
P/E ratio 2023 -36,4x
Yield 2023 -
Capitalization 702 M 548 M 546 M
EV / Sales 2022 4,03x
EV / Sales 2023 2,90x
Nbr of Employees 693
Free-Float 80,3%
More Financials
Company
OrganiGram Holdings Inc is a Canada-based company, which operates through its subsidiary, Organigram Inc (Organigram). Organigram is a licensed producer of cannabis and extract-based products. The Company is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis... 
More about the company
Ratings of OrganiGram Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ORGANIGRAM HOLDINGS INC.
12/03S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index
AQ
12/03Ovation Science Develops New High Dose CBD Formulations for Health and Wellness, Beauty..
MT
12/03Humble & Fume Details Sales and Distribution Partnership with PAX Labs, Inc.
MT
12/03Humble & Fume, PAX Labs Enter Partnership for PAX-Branded Vape Devices in Canada
MT
12/03Gage Growth Receives DTC Eligibility, Closes Purchase of Sturgis, Mi., Dispensary
MT
12/02Tilray Launches Fast-Acting Medical Cannabis Oral Strips
MT
12/02High Tide Taps Alpine IQ to Manage Loyalty Program
MT
12/02HIGH TIDE BRIEF : Details Partnership With Alpine IQ, a Data and Marketing Solutions Provi..
MT
12/01Zelira Therapeutics Secures Ethics Approval for Phase 2 Trial of Chronic Pain Drug; Sha..
MT
12/01YELLEN : bank access for cannabis firms would aid U.S. tax collections
RE
12/01Delta 9 Opens US Showroom for Grow Pod Sales
MT
11/30Harborside Raising Up To US$10 Million Concurrently with M&A Transactions
MT
11/29ECS Botanics, Cannvalate Enter $3.5 Million Medicinal Cannabis Resin Supply Deal; Share..
MT
11/29Cann Group Selling 8.36%Stake in Zalm Therapeutics
MT
11/29Cannabis Industry Lender Chicago Atlantic Real Estate Finance Files for IPO
MT
More news
News in other languages on ORGANIGRAM HOLDINGS INC.
12/02Tilray lance des bandes orales de cannabis médical à action rapide
12/02Pistorius sieht Legalisierung von Cannabis kritisch
12/01Zelira Therapeutics obtient l'approbation éthique pour un essai de phase 2 sur un médic..
12/01AKTIEN FRANKFURT : Dax auf Erholungskurs
12/01AKTIEN FRANKFURT ERÖFFNUNG : Stabilisierungsversuch im unruhigen Umfeld
More news
Analyst Recommendations on ORGANIGRAM HOLDINGS INC.
More recommendations
Chart ORGANIGRAM HOLDINGS INC.
Duration : Period :
OrganiGram Holdings Inc. Technical Analysis Chart | OGI | CA68620P1018 | MarketScreener
Technical analysis trends ORGANIGRAM HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 2,34 CAD
Average target price 3,46 CAD
Spread / Average Target 47,8%
EPS Revisions
Managers and Directors
Beena G. Goldenberg Chief Executive Officer & Director
Derrick W. West Chief Financial Officer
Peter Amirault Executive Chairman
Nathalie Batten Vice President-Operations
Dexter D. S. John Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ORGANIGRAM HOLDINGS INC.43.79%548
HARVEST HEALTH & RECREATION INC.42.91%1 363
COLUMBIA CARE INC.-50.84%1 102
AYR WELLNESS INC.-34.08%1 009
CANSORTIUM INC.-1.32%187
RUBICON ORGANICS INC.-45.03%90